Published in J Lipid Res on December 18, 2009
FXR signaling in the enterohepatic system. Mol Cell Endocrinol (2012) 1.32
Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol (2010) 1.29
Pleiotropic functions of the organic solute transporter Ostα-Ostβ. Dig Dis (2011) 0.82
Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice. J Steroid Biochem Mol Biol (2012) 0.82
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Identification of a nuclear receptor for bile acids. Science (1999) 7.81
Bile acids: natural ligands for an orphan nuclear receptor. Science (1999) 7.18
TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91
A G protein-coupled receptor responsive to bile acids. J Biol Chem (2003) 4.76
Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell (1999) 4.76
Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun (2002) 3.41
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun (2005) 3.38
Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem (2008) 1.85
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology (2007) 1.69
Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. J Med Chem (2007) 1.28
Study of reticuloendothelial phagocytic capacity in patients with cholestasis. Br Med J (1976) 1.09
Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci (2005) 1.04
Conversion of 7-alpha,12-alpha-dihydroxycholest-4-en-3-one to 5-alpha-cholestane-3-alpha, 7-alpha,12-alpha-triol by iguana liver microsomes. J Lipid Res (1968) 1.02
Bile salts of anura. Chem Pharm Bull (Tokyo) (1973) 0.97
Steady-state kinetics of serum bile acids in healthy human subjects: single and dual isotope techniques using stable isotopes and mass spectrometry. J Lipid Res (1987) 0.94
Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor. J Lipid Res (2004) 0.91
Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. J Lipid Res (2003) 0.86
Synthesis of 5beta-cholestane-3alpha, 7alpha, 12alpha, 25-tetrol and 5beta-cholestane-3alpha, 7alpha, 245, 25-pentol. J Lipid Res (1976) 0.86
Circadian distribution of bile acid in the enterohepatic circulatory system in hamsters. J Lipid Res (1976) 0.84
Bile salts of frogs: a new higher bile acid, 3 alpha, 7 alpha, 12 alpha, 26-tetrahydroxy-5 beta-cholestanoic acid from the bile Rana plancyi. J Lipid Res (1980) 0.82
5Alpha-bile alcohols function as farnesoid X receptor antagonists. Biochem Biophys Res Commun (2005) 0.82
Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J Am Coll Surg (1995) 0.81
Preparation of 24(R)- and 24(S)-5beta-cholestane-3alpha,7alpha,24-triols and 25(R)- and 25(S)-5beta-cholestane-3alpha,7alpha,26-triols by a hydroboration procedure. J Lipid Res (1978) 0.81
Identification of bile alcohols in human bile. J Lipid Res (1985) 0.81
Synthesis of new bile salt analogues, sodium 3 alpha, 7 alpha-dihydroxy-5 beta-cholane-24-sulfonate and sodium 3 alpha, 7 beta-dihydroxy-5 beta-cholane-24-sulfonate. J Lipid Res (1990) 0.79
Structure-activity relationship of bile alcohols as human farnesoid X receptor agonist. Steroids (2009) 0.79
Formation and metabolism of bile alcohols in man. Hepatology (1984) 0.78
Impairment of human lymphocyte function by bile salts. Surgery (1984) 0.78
Synthesis of biological precursors of cholic acid II. Steroids (1981) 0.77
Synthesis of sulfonate analogs of bile acids. Steroids (1992) 0.77
Synthesis and metabolism of sodium 3 alpha,7 alpha-dihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate in the hamster. Lipids (1995) 0.77
The identification of urinary bile alcohols by gas chromatography-mass spectrometry in patients with liver disease and in healthy individuals. Eur J Clin Invest (1983) 0.77
Synthesis of (22R and 22S)-3 alpha, 7 alpha, 22-trihydroxy-5 beta-cholan-24-oic acids and structure of haemulcholic acid, a unique bile acid isolated from fish bile. J Lipid Res (1981) 0.77
Identification of new bile alcohols, 5 beta-cholestane-3 alpha,7 alpha,24,26-tetrol, 5 beta-cholestane-3 alpha,7 alpha,25,26-tetrol, and 5 beta-cholestane-3 alpha,7 alpha,26,27-tetrol in human gallbladder bile. J Lipid Res (1986) 0.77
New bile alcohols--synthesis of 5beta-cholestane-3alpha, 7alpha, 25-triol and 5beta-cholestane-3alpha, 7alpha, 25-24 (14C)-triol. Steroids (1975) 0.77
Stero-bile acids and bile sterols. LXXIV. Biosynthesis of bile acids and bile alcohols in toad. J Biochem (1965) 0.77
Stero-bile acids and bile sterols. 36. Isolation of a new bile sterol, 3 alpha, 7 alpha, 12 alpha, 26-tetrahydroxy-delta23-bishomocholene, from bull frog bile. J Biochem (1961) 0.77
Chemistry and metabolism of bile alcohols and higher bile acids. Adv Lipid Res (1968) 0.76
Synthesis of biological precursors of cholic acid. Steroids (1978) 0.76
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet (2003) 7.98
Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small-intestinal diseases. Clin Gastroenterol Hepatol (2004) 3.04
The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood (2010) 2.05
Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem (2008) 1.85
Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner. Arterioscler Thromb Vasc Biol (2005) 1.64
Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem (2011) 1.62
Specific IgE response to trichophyton and asthma severity. Chest (2009) 1.49
Mapping a quantitative trait locus for resistance to bacterial grain rot in rice. Rice (N Y) (2013) 1.45
Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol (2011) 1.44
Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial. Int J Urol (2013) 1.42
Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant (2006) 1.41
Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts. Respirology (2015) 1.40
Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol (2004) 1.32
Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. J Med Chem (2007) 1.28
Clinical outcomes of enteroscopy using the double-balloon method for strictures of the small intestine. World J Gastroenterol (2005) 1.17
Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clin Endocrinol Metab (2007) 1.16
Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. J Biol Chem (2007) 1.10
Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem (2002) 1.09
Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase. J Virol (2003) 1.08
Survival of parvovirus B19-infected cells by cellular autophagy. Virology (2006) 1.08
Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol (2006) 1.07
L-Glutamine or L-alanyl-L-glutamine prevents oxidant- or endotoxin-induced death of neonatal enterocytes. Amino Acids (2009) 1.06
Nonsurgical management of small-bowel polyps in Peutz-Jeghers syndrome with extensive polypectomy by using double-balloon endoscopy. Gastrointest Endosc (2011) 1.05
Sibling cases of Vici syndrome: sleep abnormalities and complications of renal tubular acidosis. Am J Med Genet A (2007) 1.03
Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp Biol Med (Maywood) (2005) 1.01
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients. Cancer Chemother Pharmacol (2009) 1.01
Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation. Int J Hematol (2008) 1.01
Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer. J Clin Oncol (2004) 1.00
First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component. J Thorac Oncol (2012) 1.00
[QTL analysis of sheath blight resistance in rice (Oryza sativa L.)]. Yi Chuan Xue Bao (2002) 1.00
Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS One (2012) 0.99
Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest (2007) 0.97
Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease. Lipids Health Dis (2013) 0.97
Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration (2011) 0.96
Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy. J Mol Cell Cardiol (2013) 0.95
Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol (2005) 0.95
TGFB1 promoter polymorphism C-509T and pathophysiology of asthma. J Allergy Clin Immunol (2007) 0.95
Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Am J Hematol (2008) 0.94
Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages. Arterioscler Thromb Vasc Biol (2011) 0.93
Prognosis of cough variant asthma: a retrospective analysis. J Asthma (2006) 0.92
Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib. J Thorac Oncol (2015) 0.91
Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor. J Lipid Res (2004) 0.91
Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism. Arterioscler Thromb Vasc Biol (2004) 0.91
Favorable surgical results for patients with nonsmall cell lung cancer over 80 years old: a multicenter survey. Ann Thorac Cardiovasc Surg (2008) 0.91
Relationship between small airway function and health status, dyspnea and disease control in asthma. Respiration (2009) 0.90
Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters. J Pharmacol Sci (2010) 0.90
Prevalence and clinical manifestations of gastro-oesophageal reflux-associated chronic cough in the Japanese population. Cough (2007) 0.90
Relationship between exercise tolerance and muscle strength following cardiac rehabilitation: comparison of patients after cardiac surgery and patients with myocardial infarction. J Cardiol (2009) 0.90
Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. Dig Dis Sci (2003) 0.89
The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Exp Hematol (2007) 0.89
An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene. Lung Cancer (2013) 0.89
Cough triggers and their pathophysiology in patients with prolonged or chronic cough. Allergol Int (2012) 0.89
The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL. J Lipid Res (2002) 0.88
Mapping and validation of QTLs for rice sheath blight resistance. Breed Sci (2013) 0.88
Double-balloon enteroscopy through a Roux-en-Y anastomosis for EMR of an early carcinoma in the afferent duodenal limb. Gastrointest Endosc (2004) 0.88
Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation. J Biol Chem (2010) 0.88
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients. Br J Clin Pharmacol (2010) 0.87
A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes. Arch Virol (2011) 0.87
Secondary mutations at I1171 in the ALK gene confer resistance to both Crizotinib and Alectinib. J Thorac Oncol (2014) 0.87
Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features. Cancer (2006) 0.87
Dramatic response to crizotinib in an ALK-positive adenocarcinoma patient with disseminated intravascular coagulation. J Thorac Oncol (2013) 0.86
Antioxidative role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Int J Mol Med (2005) 0.86
Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. J Lipid Res (2003) 0.86
Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice. Lab Invest (2009) 0.86
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Am J Hematol (2008) 0.86
Docosahexaenoic acid induces adipose differentiation-related protein through activation of retinoid x receptor in human choriocarcinoma BeWo cells. Biol Pharm Bull (2009) 0.85
Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma. Respiration (2011) 0.85
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Am J Hematol (2007) 0.85
Patients' characteristics associated with unsuccessful sputum induction in asthma. J Allergy Clin Immunol (2008) 0.85
Stable lariat formation based on a G-quadruplex scaffold. J Am Chem Soc (2008) 0.85
Multimodal treatment for resectable epithelial type malignant pleural mesothelioma. World J Surg Oncol (2004) 0.85
Gatifloxacin induces augmented insulin release and intracellular insulin depletion of pancreatic islet cells. Biol Pharm Bull (2007) 0.85
Long-term Outcomes in Patients with Small Intestinal Strictures Secondary to Crohn's Disease After Double-balloon Endoscopy-assisted Balloon Dilation. Inflamm Bowel Dis (2016) 0.84
False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother (2007) 0.84
Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients. J Pharm Sci (2011) 0.84
Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation. J Biochem (2012) 0.84
Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice. Immunopharmacol Immunotoxicol (2009) 0.84
Efficacy of intravitreal bevacizumab (Avastin) for short-term treatment of diabetic macular edema. J Med Invest (2009) 0.84
Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance. Surg Today (2013) 0.84
Development of multidrug resistance due to multiple factors including P-glycoprotein overexpression under K-selection after MYC and HRAS oncogene activation. Int J Cancer (2006) 0.84
Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells. Cancer Sci (2013) 0.83
Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients. J Antimicrob Chemother (2007) 0.83
Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry. Surgery (2002) 0.83
Accurate evaluation of the absorption maxima of retinal proteins based on a hybrid QM/MM method. J Comput Chem (2006) 0.83
Inflammatory subtypes in cough-variant asthma: association with maintenance doses of inhaled corticosteroids. Chest (2010) 0.82
Two cases of subungual melanoma in situ. J Dermatol (2008) 0.82
Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. Drug Metab Pharmacokinet (2008) 0.82
PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine. Biochem Biophys Res Commun (2008) 0.82
5Alpha-bile alcohols function as farnesoid X receptor antagonists. Biochem Biophys Res Commun (2005) 0.82
Effect of body mass index on perioperative complications in thoracic surgery. Asian Cardiovasc Thorac Ann (2008) 0.82
Association of alveolar nitric oxide levels with pulmonary function and its reversibility in stable asthma. Respiration (2010) 0.81
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy. Int J Clin Oncol (2013) 0.81
Three-base deletion and one-base insertion of the alpha(1,4)galactosyltransferase gene responsible for the P phenotype. Transfusion (2002) 0.81
Pitavastatin increases ABCA1 expression by dual mechanisms: SREBP2-driven transcriptional activation and PPARα-dependent protein stabilization but without activating LXR in rat hepatoma McARH7777 cells. J Pharmacol Sci (2011) 0.81
Features of cough variant asthma and classic asthma during methacholine-induced brochoconstriction: a cross-sectional study. Cough (2009) 0.81